Multi-drug resistance protein 1 as prognostic biomarker in clinical practice for acute myeloid leukemia-Reference-Cited by-同舟云学术

Multi-drug resistance protein 1 as prognostic biomarker in clinical practice for acute myeloid leukemia

Published:2016-06-20 Issue:5 Volume:38 Page:e93-e97
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int. Jnl. Lab. Hem.

Author:

Gupta R.¹,Chandgothia M.¹,Dahiya M.¹,Bakhshi S.¹,Sharma A.¹,Kumar L.¹

Affiliation:

1. All India Institute of Medical Sciences; New Delhi India

Funder

AIIMS Intramural Scheme

Publisher

Wiley

Subject

Biochemistry, medical,Clinical Biochemistry,Hematology,General Medicine

Reference12 articles.

1. MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia;Schaich;Br J Haematol,2005

2. Multidrug resistance as a potential prognostic indicator in acute myeloid leukemia with normal karyotypes;Kim;Acta Haematol,2005

3. The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotype;Damiani;Haematologica,2006

4. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia;Ho;Exp Hematol,2008

5. Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy;Chauhan;Exp Mol Pathol,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters;Archives of Toxicology;2022-08-16

2. ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia;Biomedicine & Pharmacotherapy;2022-06

3. Update on drug transporter proteins in acute myeloid leukemia: Pathological implication and clinical setting;Critical Reviews in Oncology/Hematology;2021-04

4. Silencing thePIK3CAGene Enhances the Sensitivity of Childhood Leukemia Cells to Chemotherapy Drugs by Suppressing the Phosphorylation of Akt;Yonsei Medical Journal;2019

5. Ibrutinib improves the development of acute lymphoblastic leukemia by activating endoplasmic reticulum stress-induced cell death;PHARMAZIE;2018